These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Primary sclerosing cholangitis, a vanishing bile duct disease. van Berge Henegouwen GP Neth J Med; 1987 Aug; 31(1-2):27-35. PubMed ID: 3658059 [No Abstract] [Full Text] [Related]
3. Comparative study of FK 506, cyclosporine, and triple regimen immunosuppression with FK 506, cyclosporine, and mizoribine. Sato K; Yokota K; Matsui T; Imai K; Takishima T; Nakayama Y; Osakabe T; Yoshida M; Mieno H; Omiya H Transplant Proc; 1991 Dec; 23(6):3296-9. PubMed ID: 1721440 [No Abstract] [Full Text] [Related]
5. The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation. Ludwig J; Wiesner RH; Batts KP; Perkins JD; Krom RA Hepatology; 1987; 7(3):476-83. PubMed ID: 3552923 [TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts. Martelius T; Krogerus L; Höckerstedt K; Bruggeman C; Lautenschlager I Hepatology; 1998 Apr; 27(4):996-1002. PubMed ID: 9537439 [TBL] [Abstract][Full Text] [Related]
7. Recurrence of ductopenic rejection in liver allografts after retransplantation for vanishing bile duct syndrome. van Hoek B; Wiesner RH; Ludwig J; Paya C Transplant Proc; 1991 Feb; 23(1 Pt 2):1442-3. PubMed ID: 1703343 [No Abstract] [Full Text] [Related]
8. Reversible vanishing bile duct syndrome after liver transplantation: report of 6 cases. Hubscher SG; Buckels JA; Elias E; McMaster P; Neuberger JM Transplant Proc; 1991 Feb; 23(1 Pt 2):1415-6. PubMed ID: 1989250 [No Abstract] [Full Text] [Related]
9. Conversion from cyclosporine to bredinin in canine orthotopic liver transplantation. Uchida H; Yokota K; Sato K; Masaki Y; Osakabe T; Nakayama Y; Takishima T; Aso K Transplant Proc; 1987 Feb; 19(1 Pt 2):1290-4. PubMed ID: 3547860 [No Abstract] [Full Text] [Related]
10. Combination immunosuppression with azathioprine reduces the incidence of ductopenic rejection and vanishing bile duct syndrome after liver transplantation. van Hoek B; Wiesner RH; Ludwig J; Gores GJ; Moore B; Krom RA Transplant Proc; 1991 Feb; 23(1 Pt 2):1403-5. PubMed ID: 1989248 [No Abstract] [Full Text] [Related]
11. Pancreaticoduodenal allotransplantation with the use of FK 506, cyclosporine, and triple-regimen immunosuppression. Imai K; Sato K; Takishima T; Nakayama Y; Osakabe T; Yokota K; Yamagishi K; Uchida H; Hiki Y Transplant Proc; 1990 Aug; 22(4):1655-7. PubMed ID: 1697117 [No Abstract] [Full Text] [Related]
12. Severe ductopenic rejection with features of vanishing bile duct syndrome: clinical, biochemical, and histologic evidence for spontaneous resolution. Noack KB; Wiesner RH; Batts K; van Hoek B; Ludwig J Transplant Proc; 1991 Feb; 23(1 Pt 2):1448-51. PubMed ID: 1989260 [No Abstract] [Full Text] [Related]
13. The effect of host liver damage, portacaval shunt, and various immunosuppressive regimes on canine auxiliary liver transplantation. Macpherson SG; Miller SE; Calman KC; McSween RN; Buxton BF; Bell PR Transplantation; 1972 Aug; 14(2):175-82. PubMed ID: 4558905 [No Abstract] [Full Text] [Related]
14. [Reconstruction of the bile duct - a still unsolved problem of liver transplantation]. Strebel HM; Weber M; Scholl E Helv Chir Acta; 1974 Mar; 41(1-2):25-7. PubMed ID: 4611978 [No Abstract] [Full Text] [Related]
15. Studies on immunosuppression with low-dose cyclosporine combined with mizoribine in experimental and clinical cadaveric renal allotransplantation. Osakabe T; Uchida H; Masaki Y; Yokota K; Sato K; Nakayama Y; Ohkubo M; Kumano K; Endo T; Watanabe K Transplant Proc; 1989 Feb; 21(1 Pt 2):1598-600. PubMed ID: 2652520 [No Abstract] [Full Text] [Related]